Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maria Jung
Combination of Gemcitabine and Cisplatin Is Highly Active in Women With Endometrial Carcinoma
Cancer
Cancer Research
Oncology
Performance Evaluation of Kits for Bisulfite-Conversion of DNA From Tissues, Cell Lines, FFPE Tissues, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine
PLoS ONE
Multidisciplinary
Related publications
Phase I Dose-Escalation Study of Copanlisib in Combination With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
British Journal of Cancer
Cancer Research
Oncology
Safety and Pharmacokinetics of Motesanib in Combination With Panitumumab and Gemcitabine-Cisplatin in Patients With Advanced Cancer
Journal of Oncology
Oncology
Refractory Non-Small-Cell Lung Cancer Responding to Combination Chemotherapy With Gemcitabine and Cisplatin
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Comparison of the Efficacy Between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Chemoimmunotherapy With Brentuximab Vedotin Combined With Ifosfamide, Gemcitabine, and Vinorelbine Is Highly Active in Relapsed or Refractory Classical Hodgkin Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Curative Resection for Locally Advanced Carcinoma of the Cystic Duct After Downsizing Combination Chemotherapy With Gemcitabine and Cisplatin—Report of a Case—
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma
Anticancer Research
Medicine
Cancer Research
Oncology
Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma
Modern Chemotherapy
